The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer
Young Kwang Chae,
Debora de Melo Gagliato,
Sachin Gopalkrishna Pai,
Benedito Carneiro,
Nisha Mohindra,
Francis Joseph Giles,
Praveen Ramakrishnan-Geethakumari,
Joohyuk Sohn,
Shuying Liu,
Huiqin Chen,
Naoto Ueno,
Gabriel Hortobagyi and
Ana Maria Gonzalez-Angulo
PLOS ONE, 2016, vol. 11, issue 4, 1-12
Abstract:
EGFR and cMET cross-talk is involved in breast cancer (BC) progression and resistance to different targeted therapies, however little is known about the co-expression patterns of EGFR and cMET or its prognostic significance in BC. Protein levels of EGFR, cMET and their phosphorylated proteins were measured in 825 BC samples using reverse phase protein array (RPPA). Given unimodal distribution of proteins, the median was selected as a cut-off after sensitivity analyses. Kaplan-Meier survival curves were used to estimate relapse-free (RFS) and overall survival (OS). Cox-proportional hazards models were utilized to determine associations between EGFR and cMET with outcomes. Mean age was 58 years with 457 (55%) hormone receptor (HR) positive, 211 (26%) triple-negative (TN) and 148 (18%) HER2 positive tumors (HER2+). HER2+ was associated with higher EGFR expression and phosphorylation, compared to HR and TN (p
Date: 2016
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152585 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 52585&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0152585
DOI: 10.1371/journal.pone.0152585
Access Statistics for this article
More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().